No biomarker
No biomarker
|
Gastroesophageal Junction Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
|
nivolumab
Bristol-Myers Squibb Press Release - Today
|
No biomarker
No biomarker
|
Esophageal Cancer
Esophageal Cancer
|
nivolumab
Bristol-Myers Squibb Press Release - Today
|
No biomarker
No biomarker
|
Acute Lymphocytic Leukemia
ALL
|
eryaspase
Sensitive: B - Late Trials
- 1 day
|
No biomarker
No biomarker
|
Mantle Cell Lymphoma
Mantle Cell Lymphoma
|
zanubrutinib
BeiGene Press Release - 4 days
|
No biomarker
No biomarker
|
Triple Negative Breast Cancer
Triple Negative Breast Cancer
|
pembrolizumab
FDA - 4 days
|
No biomarker
No biomarker
|
|
nanoparticle albumin-bound rapamycin
Sensitive: B - Late Trials
- 4 days
|
No biomarker
No biomarker
|
Small Cell Lung Cancer
Small Cell Lung Cancer
|
durvalumab
AstraZeneca Press Release - 1 week
|
No biomarker
No biomarker
|
Endometrial Cancer
Endometrial Cancer
|
pembrolizumab + lenvatinib
FDA - 1 week
|
No biomarker
No biomarker
|
Acute Lymphocytic Leukemia
ALL
|
recombinant Erwinia asparaginase
Jazz Pharma Press Release - 1 week
|
No biomarker
No biomarker
|
Triple Negative Breast Cancer
Triple Negative Breast Cancer
|
trilaciclib
Sensitive: B - Late Trials
G1 Therapeutics Press Release - 1 week
|
No biomarker
No biomarker
|
Myelodysplastic Syndrome
MDS
|
venetoclax
Sensitive: B - Late Trials
Roche Press Release - 1 week
|
No biomarker
No biomarker
|
Multiple Myeloma
Multiple Myeloma
|
pomalidomide + daratumumab/hyaluronidase
J&J Press Release - 2 weeks
|
No biomarker
No biomarker
|
Lung Non-Small Cell Squamous Cancer
Lung Non-Small Cell Squamous Cancer
|
nivolumab + ipilimumab
Sensitive: A2 - Guideline
JAMA Oncol - 2 weeks
|
No biomarker
No biomarker
|
Multiple Myeloma
Multiple Myeloma
|
carfilzomib
BeiGene Press Release - 3 weeks
|
No biomarker
No biomarker
|
Prostate Cancer
Prostate Cancer
|
enzalutamide
NICE - 3 weeks
|
No biomarker
No biomarker
|
Multiple Myeloma
Multiple Myeloma
|
pomalidomide + elotuzumab
|
No biomarker
No biomarker
|
Diffuse Large B Cell Lymphoma
Diffuse Large B Cell Lymphoma
|
|
No biomarker
No biomarker
|
Non Small Cell Lung Cancer
NSCLC
|
|
No biomarker
No biomarker
|
Non Small Cell Lung Cancer
NSCLC
|
|
No biomarker
No biomarker
|
|
nivolumab + cabozantinib tablet
|
No biomarker
No biomarker
|
Malignant Pleural Mesothelioma
Malignant Pleural Mesothelioma
|
|
No biomarker
No biomarker
|
Follicular Lymphoma
Follicular Lymphoma
|
|
No biomarker
No biomarker
|
Diffuse Large B Cell Lymphoma
Diffuse Large B Cell Lymphoma
|
|
No biomarker
No biomarker
|
Mediastinal B Cell Lymphoma
Mediastinal B Cell Lymphoma
|
|
No biomarker
No biomarker
|
Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
|
|
No biomarker
No biomarker
|
Fallopian Tube Cancer
Fallopian Tube Cancer
|
|
No biomarker
No biomarker
|
Ovarian Cancer
Ovarian Cancer
|
|
No biomarker
No biomarker
|
Peritoneal Cancer
Peritoneal Cancer
|
|
No biomarker
No biomarker
|
Mantle Cell Lymphoma
Mantle Cell Lymphoma
|
brexucabtagene autoleucel
|
No biomarker
No biomarker
|
Esophageal Adenocarcinoma
Esophageal Adenocarcinoma
|
|
No biomarker
No biomarker
|
Non-Hodgkin’s Lymphoma
NHL
|
|
No biomarker
No biomarker
|
Gastric Cancer
Gastric Cancer
|
|
No biomarker
No biomarker
|
Non Small Cell Lung Cancer
NSCLC
|
|
No biomarker
No biomarker
|
Non Small Cell Lung Cancer
NSCLC
|
|
No biomarker
No biomarker
|
Squamous Cell Carcinoma of Head and Neck
SCCHN
|
cisplatin + 5-fluorouracil + docetaxel
|
No biomarker
No biomarker
|
Gastric Adenocarcinoma
Gastric Adenocarcinoma
|
cisplatin + 5-fluorouracil + docetaxel
|
No biomarker
No biomarker
|
Gastroesophageal Junction Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
|
cisplatin + 5-fluorouracil + docetaxel
|
No biomarker
No biomarker
|
Non Small Cell Lung Cancer
NSCLC
|
|
No biomarker
No biomarker
|
Breast Cancer
Breast Cancer
|
docetaxel + doxorubicin hydrochloride + cyclophosphamide oral
|
No biomarker
No biomarker
|
|
|
No biomarker
No biomarker
|
Lung Non-Squamous Non-Small Cell Cancer
Lung Non-Squamous Non-Small Cell Cancer
|
|
No biomarker
No biomarker
|
Thyroid Gland Medullary Carcinoma
Thyroid Gland Medullary Carcinoma
|
|
No biomarker
No biomarker
|
Non Small Cell Lung Cancer
NSCLC
|
|
No biomarker
No biomarker
|
Lung Non-Squamous Non-Small Cell Cancer
Lung Non-Squamous Non-Small Cell Cancer
|
|
No biomarker
No biomarker
|
Small Cell Lung Cancer
Small Cell Lung Cancer
|
|
No biomarker
No biomarker
|
Acute Myelogenous Leukemia
AML
|
|
No biomarker
No biomarker
|
Hepatocellular Cancer
HCC
|
|
No biomarker
No biomarker
|
Hepatocellular Cancer
HCC
|
bevacizumab + atezolizumab
|
No biomarker
No biomarker
|
Multiple Myeloma
Multiple Myeloma
|
bortezomib + panobinostat
|
No biomarker
No biomarker
|
Multiple Myeloma
Multiple Myeloma
|
bortezomib + pegylated liposomal doxorubicin
|
No biomarker
No biomarker
|
Multiple Myeloma
Multiple Myeloma
|
|
No biomarker
No biomarker
|
Diffuse Large B Cell Lymphoma
Diffuse Large B Cell Lymphoma
|
|
No biomarker
No biomarker
|
Non Small Cell Lung Cancer
NSCLC
|
|
No biomarker
No biomarker
|
|
|
No biomarker
No biomarker
|
Diffuse Large B Cell Lymphoma
Diffuse Large B Cell Lymphoma
|
|
No biomarker
No biomarker
|
B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
|
|
No biomarker
No biomarker
|
Childhood B Acute Lymphoblastic Leukemia
Childhood B Acute Lymphoblastic Leukemia
|
|
No biomarker
No biomarker
|
Prostate Cancer
Prostate Cancer
|
|
No biomarker
No biomarker
|
Chronic Lymphocytic Leukemia
CLL
|
|
No biomarker
No biomarker
|
Squamous Cell Carcinoma of Head and Neck
SCCHN
|
|
No biomarker
No biomarker
|
Acute Myelogenous Leukemia
AML
|
|
No biomarker
No biomarker
|
Non Small Cell Lung Cancer
NSCLC
|
|
No biomarker
No biomarker
|
Gastric Cancer
Gastric Cancer
|
|
No biomarker
No biomarker
|
Urothelial Cancer
Urothelial Cancer
|
|
No biomarker
No biomarker
|
Multiple Myeloma
Multiple Myeloma
|
|
No biomarker
No biomarker
|
Gastroesophageal Junction Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
|
|
No biomarker
No biomarker
|
Squamous Cell Carcinoma of Head and Neck
SCCHN
|
|
No biomarker
No biomarker
|
Acute Myelogenous Leukemia
AML
|
cytarabine/daunorubicin liposomal formulation
|
No biomarker
No biomarker
|
Soft Tissue Sarcoma
Soft Tissue Sarcoma
|
|
No biomarker
No biomarker
|
Colon Cancer
Colon Cancer
|
|
No biomarker
No biomarker
|
Chronic Lymphocytic Leukemia
CLL
|
venetoclax + obinutuzumab
|
No biomarker
No biomarker
|
Rectal Cancer
Rectal Cancer
|
|
No biomarker
No biomarker
|
Breast Cancer
Breast Cancer
|
|
No biomarker
No biomarker
|
Urothelial Cancer
Urothelial Cancer
|
sacituzumab govitecan-hziy
|
No biomarker
No biomarker
|
Colon Cancer
Colon Cancer
|
5-fluorouracil + irinotecan
|
No biomarker
No biomarker
|
Multiple Myeloma
Multiple Myeloma
|
|
No biomarker
No biomarker
|
Burkitt Lymphoma
Burkitt Lymphoma
|
|
No biomarker
No biomarker
|
Burkitt Lymphoma
Burkitt Lymphoma
|
|
No biomarker
No biomarker
|
Adrenal Cortex Carcinoma
Adrenal Cortex Carcinoma
|
|
No biomarker
No biomarker
|
Neuroendocrine Tumor
Neuroendocrine Tumor
|
|
No biomarker
No biomarker
|
Fallopian Tube Cancer
Fallopian Tube Cancer
|
|
No biomarker
No biomarker
|
Peritoneal Cancer
Peritoneal Cancer
|
|
No biomarker
No biomarker
|
Peritoneal Cancer
Peritoneal Cancer
|
|
No biomarker
No biomarker
|
Peritoneal Cancer
Peritoneal Cancer
|
|
No biomarker
No biomarker
|
|
|
No biomarker
No biomarker
|
Peritoneal Cancer
Peritoneal Cancer
|
Mvasi (bevacizumab biosimilar)
|
No biomarker
No biomarker
|
Fallopian Tube Cancer
Fallopian Tube Cancer
|
Mvasi (bevacizumab biosimilar)
|
No biomarker
No biomarker
|
Peritoneal Cancer
Peritoneal Cancer
|
Aybintio (bevacizumab biosimilar)
|
No biomarker
No biomarker
|
Fallopian Tube Cancer
Fallopian Tube Cancer
|
Aybintio (bevacizumab biosimilar)
|
No biomarker
No biomarker
|
Fallopian Tube Cancer
Fallopian Tube Cancer
|
Onbevzi (bevacizumab biosimilar)
|
No biomarker
No biomarker
|
Peritoneal Cancer
Peritoneal Cancer
|
Onbevzi (bevacizumab biosimilar)
|
No biomarker
No biomarker
|
Fallopian Tube Cancer
Fallopian Tube Cancer
|
|
No biomarker
No biomarker
|
Fallopian Tube Cancer
Fallopian Tube Cancer
|
|
No biomarker
No biomarker
|
Peritoneal Cancer
Peritoneal Cancer
|
carboplatin + micellar paclitaxel
|
No biomarker
No biomarker
|
Fallopian Tube Cancer
Fallopian Tube Cancer
|
carboplatin + micellar paclitaxel
|
No biomarker
No biomarker
|
Prostate Cancer
Prostate Cancer
|
|
No biomarker
No biomarker
|
Prostate Cancer
Prostate Cancer
|
|
No biomarker
No biomarker
|
Retinoblastoma
Retinoblastoma
|
|
No biomarker
No biomarker
|
Mantle Cell Lymphoma
Mantle Cell Lymphoma
|
|
No biomarker
No biomarker
|
Small Lymphocytic Lymphoma
Small Lymphocytic Lymphoma
|
|
No biomarker
No biomarker
|
Chronic Lymphocytic Leukemia
CLL
|
|
No biomarker
No biomarker
|
|
Byvasda (bevacizumab biosimilar)
|
No biomarker
No biomarker
|
Neuroendocrine Tumor
Neuroendocrine Tumor
|
|
No biomarker
No biomarker
|
|
|
No biomarker
No biomarker
|
Mantle Cell Lymphoma
Mantle Cell Lymphoma
|
|
No biomarker
No biomarker
|
Chronic Myeloid Leukemia
CML
|
omacetaxine mepesuccinate
|
No biomarker
No biomarker
|
|
Mvasi (bevacizumab biosimilar)
|
